Category: Anemia

Peginesatide Overview

Peginesatide[2] (INN/USAN, trade name Omontys, formerly Hematide), developed by Affymax and Takeda, is an erythropoietic agent, a functional analog of erythropoietin. It was approved by the U.S. Food and Drug Administration for treatment of anemia associated with chronic kidney disease (CKD) in adult patients on dialysis.[3][4] On February 23, 2013, Affymax and Takeda issued a press release indicating that they were recalling all batches of pegi...

Read more Peginesatide Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Peginesatide Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

  • Injection: 1mg/0.5ml, 2mg/0.5ml, 3mg/0.5ml, 4mg/0.5ml, 5mg/0.5ml, 6mg/0.5ml
  • Solution: 10mg/ml (10mg/ml), 1mg/0.5ml (1mg/0.5ml), 20mg/2ml (10mg/ml), 2mg/0.5ml (2mg/0.5ml), 3mg/0.5ml (3mg/0.5ml), 4mg/0.5ml (4mg/0.5ml), 5mg/0.5ml (5mg/0.5ml), 6mg/0.5ml (6mg/0.5ml)
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Peginesatide or a similar ingredient: (1 result)

Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 16 April 2021.

We are committed to your privacy.

Copyright © 2005-2021 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA